✦ LIBER ✦

An open study of paroxetine in hypochondriasis

✍ Scribed by Desiree B. Oosterbaan; Anton J.L.M. Van Balkom; Christine A. Van Boeijen; Tim GJ De Meij; Richard van Dyck

Book ID: 117448829
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 620 KB
Volume: 25
Category: Article
ISSN: 0278-5846
DOI: 10.1016/s0278-5846(01)00177-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paroxetine in hypochondriasis; report of

Paroxetine in hypochondriasis; report of four cases

✍ D.B. Oosterbaan; C.A. van Boeijen; A.J.L.M. van Balkom; R. van Dijck 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 133 KB

An Open Trial of Fluvoxamine for Hypocho

An Open Trial of Fluvoxamine for Hypochondriasis

✍ Brian A. Fallon; Altamash I. Qureshi; Franklin R. Schneier; Arturo Sanchez-Lacay 📂 Article 📅 2003 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 95 KB

An Open-Label Clinical Trial of Nefazodo

An Open-Label Clinical Trial of Nefazodone in Hypochondriasis

✍ Kevin D. Kjernisted; Murray W. Enns; Mark Lander 📂 Article 📅 2002 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 92 KB

Cognitive behavioral therapy versus paro

Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: An 18-month naturalistic follow-up

✍ Anja Greeven; Anton J.L.M. van Balkom; Rien van der Leeden; Jille W. Merkelbach; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Course of hypochondriasis in an internat

Course of hypochondriasis in an international primary care study

✍ Gregory E Simon; Oye Gureje; Claudio Fullerton 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Paroxetine in the treatment of depressed

Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study

✍ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a